Beta-Thalassemia Recruiting Phase 2 Trials for Sirolimus (DB00877)

Also known as: Beta-thalassemia / Thalassemia beta / Beta thalassemia / Beta thalassaemia / Beta thalassemia major / Thalassaemia beta / Beta-thalassaemia

IndicationStatusPhase
DBCOND0027982 (Beta-Thalassemia)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03877809Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent PatientsTreatment